Central regulation of the hypothalamic-pituitary-adrenal axis during fetal development in the Guinea-pig.
We have previously shown that the foetal guinea-pig hypothalamic-pituitary-adrenal (HPA) axis is activated near the time of parturition and that this is associated with changes in limbic glucocorticoid receptors (GR) and mineralocorticoid receptors. In the present study, we hypothesized that the foetal hypothalamic paraventricular nucleus (PVN) and pituitary contribute significantly to foetal HPA drive but that these areas remain sensitive to negative feedback by circulating glucocorticoids in late gestation. However, we observed decreased corticotrophin-releasing hormone mRNA expression in the PVN and decreased pro-opiomelanocortin (POMC) mRNA levels in the anterior pituitary with advanced gestational age. The reduction in POMC mRNA expression was likely the result of negative feedback via circulating glucocorticoids because GR mRNA was unchanged during development in the foetal pituitary. Furthermore, we found that maternally administered glucocorticoids significantly decreased foetal pituitary POMC mRNA expression in a dose-dependent manner at gestational day (gd) 62 with male foetuses being more sensitive to these effects. These findings show that the foetal HPA axis remains highly sensitive to glucocorticoid feedback even as plasma adrenocorticotropic hormone and cortisol levels are elevated at the end of gestation.
Owen
D
D
Department of Physiology, Facult of Medicine, University of Toronto, Medical Sciences Building, Toronto, Ontario, Canada.
Banjanin
S
S
Gidrewicz
D
D
McCabe
L
L
Matthews
S G
SG
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000235:genetics / Q000378:metabolism*; D025461:Feedback, Physiological; D005260:Female; D005865:Gestational Age; D005938:Glucocorticoids / Q000097:blood; D006168:Guinea Pigs; D007030:Hypothalamo-Hypophyseal System / Q000196:embryology* / Q000254:growth & development / Q000378:metabolism; D008297:Male; D010286:Paraventricular Hypothalamic Nucleus / Q000196:embryology / Q000378:metabolism*; D036801:Parturition / Q000502:physiology; D010902:Pituitary Gland / Q000196:embryology / Q000378:metabolism*; D010913:Pituitary-Adrenal System / Q000196:embryology* / Q000254:growth & development / Q000378:metabolism; D011247:Pregnancy; D011333:Pro-Opiomelanocortin / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D011965:Receptors, Glucocorticoid / Q000235:genetics / Q000378:metabolism*; D012727:Sex Characteristics
D005938:Glucocorticoids; D012333:RNA, Messenger; D011965:Receptors, Glucocorticoid; D011333:Pro-Opiomelanocortin; D003346:Corticotropin-Releasing Hormone